Two-Year Safety and Tolerability of Velaglucerase Alfa in Patients with Type 1 Gaucher Disease, Including Patients Switched From Imiglucerase: Phase III Trial HGT-GCB-039 and Extension,
| Autor: | Mehta, A, Turkia, H Ben *, Gonzalez, DE *, Kabra, M *, Lukina, EA *, Giraldo, P, Kisinovsky, I *, Bavdekar, A *, Dridi, M-F Ben *, Gupta, N *, Kishnani, PS *, Sureshkumar, EK *, Barton, N *, Wang, N *, Crombez, E *, Bhirangi, K *, Zimran, A |
|---|---|
| Zdroj: | In Blood 18 November 2011 118(21):3214-3214 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|